Home > Drug Search >
  • company_query: Aspyrian Therapeutics
  •   > 
Drug Filter
Category:
chemistry (7) biology (44)
Status:
Approved (10) Phase Ⅲ (11) Phase Ⅱ (10) Phase Ⅰ (20)
Clinical Stage:
Pending (5) Active (32) Discontinued (4)
Bio-Type:
Coagulation factor (1) Gene therapy (3) CAR T cell therapy (5) Recombinant cytokines (11) Recombinant hormone (1) Whole antibody (9) Fab fragment (1) Fusion protein (3)
Indication:
Acute myeloid Leukemia (AML) (1) Anemia (2) Asthma (1) Atopic dermatitis (1) Benign prostatic hypertrophy (1) Bladder cancer (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Cystic fibrosis (CF) (1) Dyslipidemia (1) Gastric cancer (1) Wet age-related macular degeneration (1) Growth hormone deficit (1) HBV infection (3) HCV infection (4) Hyperlipidemia (1) Idiopathic thrombocytopenic purpura (ITP) (1) Insomnia (1) Juvenile rheumatoid arthritis (JRA) (1) Leukemia (2) Lung cancer (1) Major depressive disorder (MDD) (1) Melanoma (2) Haematological disorders (1) Chemotherapy-induced anaemia (1) Multiple myeloma (MM) (3) Non-Hodgkin’s lymphoma (NHL) (6) Ovarian cancer (1) Pancreatic cancer (2) Pneumonia (1) Psoriatic arthritis (1) Rheumatoid arthritis (RA) (2) Solid tumours (10) Thrombocytopenia (1) Adrenoleucodystrophy (1) Head and neck cancer (1) Hodgkin lymphoma (1) Colorectal cancer (2) Ankylosing Spondylitis (AS) (2) Pain (1) Sarcoma (1) B-cell lymphoma (1) Sickle cell disease (1) Neutropenia (4) Hematological cancer (1) Sepsis (1) Mycosis fungoides (1) Staphylococcal infection (1) Plaque psoriasis (2) Thelassemia (1) hematological malignancies (1) Hemophilia (1) Hypersensitivity (1)
Aprv. Year:
2015 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top